![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Advantages with Nab-Paclitaxel in TNBC (OncLive) View |
![]() |
Five-Year Dosing, Efficacy Results for Nab-Paclitaxel in TNBC (Targeted Oncology) View |
![]() |
Nab-Paclitaxel in Metastatic Breast Cancer (OncLive) View |
![]() |
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer (ecancer) View |
![]() |
IMpassion130: results of atezolizumab plus nab-paclitaxel for frontline TNBC (VJOncology) View |
![]() |
Case 3: Atezolizumab/Nab-Paclitaxel for Triple Negative Breast Cancer (Targeted Oncology) View |
![]() |
The IMpassion130 Study in Metastatic TNBC (Targeted Oncology) View |
![]() |
Case 3: Treatment After Progression in Triple-Negative Breast Cancer (Targeted Oncology) View |
![]() |
Chemotherapeutics in Metastatic Breast Cancer (OncLive) View |
![]() |
IMPassion130: atezolizumab (atezo) + nab-paclitaxel (nab-P) vs placebo + nab-P in treatment-naiv... (Oncoletter) View |